Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ken TAKASHIMA
Adjuvant Immunotherapy for Cancer: Both Dendritic Cell-Priming and Check-Point Inhibitor Blockade Are Required for Immunotherapy
Proceedings of the Japan Academy Series B: Physical and Biological Sciences
Multidisciplinary
Biological Sciences
Medicine
Agricultural
Astronomy
Physics
Related publications
Dendritic Cell-Based Immunotherapy for Prostate Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
Journal of Immunology
Allergy
Immunology
Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
Advanced Materials
Mechanics of Materials
Materials Science
Nanotechnology
Mechanical Engineering
Nanoscience
Dendritic Cell-Based Immunotherapy
Cell Research
Cell Biology
Molecular Biology
CCL2 Blockade Augments Cancer Immunotherapy
Cancer Research
Cancer Research
Oncology
Immunotherapy of Cancer With Dendritic Cell-Based Vaccines
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Dendritic Cell-Based Immunotherapy of Breast Cancer: Modulation by CpG
Immunotherapy for Gastrointestinal Cancer
Gastroenterology
Hepatology
Gastroenterology
Immunotherapy for Cervical Cancer
BioDrugs
Medicine
Biotechnology
Pharmacology